Advertisement
Home 2016

Archives

When breast cancer spreads to the brain

SABCS: Molecular Changes Occur When Breast CA Spreads to Brain

0
Finding might lead to better treatment, researchers say
More than one in 10 stroke survivors develop epilepsy

Epilepsy Onset Not Uncommon After Stroke

0
Patients with greater brain damage more likely to have seizures afterwards, researchers find
Patients with epilepsy who experience longer seizures during a simulated driving test may face an increased risk for crashes while on the road

Measures Sought to ID Epilepsy Patients Who Are Safe to Drive

0
Those with longer seizures during driving tests more likely to have accidents
According to the results of several trials presented at the annual meeting of the American Epilepsy Society

Cannabidiol May Help Treat Intractable Epilepsy

0
CBD lowers seizure frequency, severity in some patients with Dravet, Lennox-Gastaut syndromes
Older breast cancer survivors taking letrozole for more than the recommended five years may not live longer; however

SABCS: No Survival Benefit Seen for Letrozole Beyond Five Years

0
Study found women who continued with letrozole did experience other benefits, however
According to a presentation at the annual meeting of the American Society of Hematology

ASH: Synthetic Blood Cell Passes Proof-of-Concept Testing

0
Synthetic product made from purified human hemoglobin proteins coated with a synthetic polymer
Many infants with infantile spasms aren't promptly diagnosed

Diagnosis of Infantile Spasms Too Often Delayed

0
Parents, doctors may not recognize infantile spasms early enough to prevent brain damage
Sleep deprivation while working 24-hour shifts can affect heart function

RSNA: Sleep Deprivation Appears to Affect Heart Function

0
Small study finds lack of sleep affects blood pressure, heart rate in healthy volunteers
For adults with mild cognitive impairment

RSNA: Improved Brain Volume With Aerobic Intervention in MCI

0
Improvement noted in executive function in aerobic exercise group after six months
The experimental drug CB-839 shows promise in treating kidney cancer

Drug Shows Promise in Clear Cell, Papillary Renal Cell Cancer

0
93 percent had tumor growth controlled for median of more than eight months, researchers report